PetMed Express (NASDAQ:PETS) Cut to “Hold” at StockNews.com

2025-04-26T07:13:11Z

StockNews.com downgraded shares of PetMed Express (NASDAQ:PETS – Free Report) from a buy rating to a hold rating in a research note published on Wednesday morning. Separately, Morgan Stanley lowered their price target on PetMed Express from $3.50 to $3.20 and…

StockNews.com downgraded shares of PetMed Express (NASDAQ:PETS – Free Report) from a buy rating to a hold rating in a research note published on Wednesday morning.

Separately, Morgan Stanley lowered their price target on PetMed Express from $3.50 to $3.20 and set an “underweight” rating on the stock in a research report on Thursday, April 17th.

Get PetMed Express alerts:

Check Out Our Latest Report on PetMed Express

PetMed Express Stock Performance

Shares of PetMed Express stock opened at $3.50 on Wednesday. The firm has a market cap of $72.30 million, a P/E ratio of 350.35 and a beta of 0.99. The firm’s 50-day simple moving average is $3.82 and its 200-day simple moving average is $4.46. PetMed Express has a twelve month low of $2.90 and a twelve month high of $6.85.

PetMed Express (NASDAQ:PETS – Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. On average, equities analysts forecast that PetMed Express will post 0.19 earnings per share for the current fiscal year.

Institutional Trading of PetMed Express

Several large investors have recently added to or reduced their stakes in PETS. R Squared Ltd acquired a new position in shares of PetMed Express in the 4th quarter worth approximately $31,000. Quarry LP bought a new position in PetMed Express in the 4th quarter valued at $47,000. Virtu Financial LLC bought a new position in PetMed Express in the 4th quarter valued at $58,000. Boothbay Fund Management LLC acquired a new position in PetMed Express in the fourth quarter worth $59,000. Finally, Squarepoint Ops LLC grew its holdings in shares of PetMed Express by 41.4% during the fourth quarter. Squarepoint Ops LLC now owns 17,686 shares of the company’s stock worth $85,000 after purchasing an additional 5,180 shares during the last quarter. 73.33% of the stock is owned by institutional investors.

About PetMed Express

(Get Free Report)

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.